OneMedNet Corp (ONMD)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenue | 155 | 137 | 142 | 227 |
| Cost of revenue | 396 | 361 | 226 | 329 |
| Gross margin | -241 | -224 | -84 | -102 |
| Sales and marketing | 257 | 290 | 140 | 253 |
| Research and development | 382 | 348 | 298 | 383 |
| General and administrative | 1,183 | 1,362 | 1,865 | 1,716 |
| Total operating expenses | 1,822 | 2,000 | 2,303 | 2,352 |
| Loss from operations | -2,063 | -2,224 | -2,387 | -2,454 |
| Emdedded derivative liabilities | - | - | - | -160 |
| Changeinfairvalueofnote | - | - | - | -823 |
| Gain (loss) on derivative instruments, net, pretax | - | - | 160 | - |
| Other expense | -12 | - | -4 | -20 |
| Interest expense | 22 | 31 | 36 | 41 |
| Realized gain on sale of crypto assets bitcoin | 314 | 531 | - | - |
| Change in fair value of warrants | - | 3 | 6 | 6 |
| Change in fair value of derivative liability | 110 | 324 | - | - |
| Change in fair value of crypto assets bitcoin | -174 | -662 | -124 | - |
| Stock warrant expense | - | - | - | 33 |
| Gain on troubled debt restructurings | 3,707 | - | - | - |
| Change in fair value of yorkville note | -34 | -30 | -262 | - |
| Change in fair value of pipe notes | -1,088 | -133 | -77 | 52 |
| Total other expense (income), net | 5,045 | 322 | 329 | -1,135 |
| Net income (loss) | 2,982 | -1,902 | -2,058 | -3,589 |
| Net income (loss) per share attributable to common shares basic | 0.07 | -0.06 | -0.07 | -0.15 |
| Net income (loss) per share attributable to common shares diluted | 0.07 | -0.06 | -0.07 | -0.15 |
| Weighted average shares of common stock outstanding basic | 36,835,945 | 34,103,724 | 27,878,399 | 23,940,120 |
| Weighted average shares of common stock outstanding diluted | 38,405,921 | 34,103,724 | 27,878,399 | 23,940,120 |